Paan Capital

The three named partners — Paweł Kapłon, Marcin Mierzwiński, and Mariusz Jabłoński — collectively lead investment decisions. The firm does not publicly identify an investment committee beyond these individuals, and the partner group's biographies describe direct involvement in sourcing, executing, and managing portfolio companies.

The firm's public disclosures do not reference a committed fund structure or external limited partners. Its website and transaction history suggest it deploys capital directly — likely a combination of partner equity and deal-specific co-investment — rather than through a blind-pool fund.

Paan Capital embeds its partners into operational roles at portfolio companies. One partner served as CEO of Polotrend for 18 months post-acquisition; another previously led the transformation of Simple Creative Products as CEO after orchestrating its buyout. This hands-on, executive-level operating model is the firm's stated point of differentiation in the Polish mid-market.

The firm describes a flexible mandate spanning growth equity, buyouts, and restructuring situations. Confirmed investments range from an e-grocery scale-up (Frisco) to a controlling stake in a clinical-stage biotech (PolTREG), indicating appetite for both proven business models and early-commercialization healthcare assets, typically in Poland.

The partner group blends all three backgrounds. Kapłon and Mierzwiński came through Ernst & Young's transaction advisory and corporate finance practices; Jabłoński joined from general management roles at Philips Healthcare and Eli Lilly. This hybrid of M&A advisory and line-management experience shapes the firm's deal-execution and operational-intervention model.

The firm's public materials do not explicitly solicit or describe formal co-investment programs. However, its website references transaction experience 'with private equity funds' and assisting companies in 'obtaining an industry investor,' suggesting Paan Capital syndicates selectively with financial and strategic partners on a deal-by-deal basis.

There is no public record of a philanthropic foundation, venture-philanthropy arm, or parallel fund vehicle associated with Paan Capital or its partners.